260 related articles for article (PubMed ID: 16783989)
1. [Oral antidiabetic agents: which role in 2006?].
Gasteyger C; Egli M
Rev Med Suisse; 2006 May; 2(68):1446-50, 1452. PubMed ID: 16783989
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapies for diabetes management: an update for the practicing clinician.
Meneghini L; Hirsch IB
Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic drugs: preoperative stop or continue?
Poortmans G
Acta Anaesthesiol Belg; 2001; 52(4):403-7. PubMed ID: 11799573
[TBL] [Abstract][Full Text] [Related]
5. [Oral antidiabetics of the sulfonylurea group and their problems in therapy].
Füsgen I; Summa JD
Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613
[TBL] [Abstract][Full Text] [Related]
6. [Practical management of oral antidiabetics in patients with renal disease].
Alcazar R; Gonzalez Albarran O; Honorato J; Robles NR; Acha J; de Alvaro F; Fernandez Gallego V; Gomez Garcia P; Lopez de la Torre M; Martinez Castelao A; Romero R
Nefrologia; 2006; 26(5):538-58. PubMed ID: 17117897
[No Abstract] [Full Text] [Related]
7. [Oral antidiabetics (hypoglycemic sulfamides and biguanides)].
Vigne J
Brux Med; 1974 Feb; 54(2):91-7. PubMed ID: 4434244
[No Abstract] [Full Text] [Related]
8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
9. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
Koski RR
Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
[TBL] [Abstract][Full Text] [Related]
10. [Oral treatment of type 2 diabetes mellitus].
Olsovský J
Vnitr Lek; 2007; 53(7-8):853-4, 856-8. PubMed ID: 17915430
[TBL] [Abstract][Full Text] [Related]
11. [Oral antidiabetic drugs].
Aarseth S
Tidsskr Nor Laegeforen; 1971 Nov; 91(17):1330-6. PubMed ID: 4935814
[No Abstract] [Full Text] [Related]
12. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
Campbell RK
Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
[TBL] [Abstract][Full Text] [Related]
13. [Oral antidiabetics].
Bachmann W
Med Welt; 1983 Feb; 34(5):129-32. PubMed ID: 6843336
[No Abstract] [Full Text] [Related]
14. Psychoactive drug interactions with pharmacotherapy for diabetes.
DeVane CL; Markowitz JS
Psychopharmacol Bull; 2002; 36(2):40-52. PubMed ID: 12397839
[TBL] [Abstract][Full Text] [Related]
15. New antidiabetic therapies: innovative strategies for an old problem.
Lehrke M; Marx N
Curr Opin Lipidol; 2012 Dec; 23(6):569-75. PubMed ID: 23069986
[TBL] [Abstract][Full Text] [Related]
16. [Letter: Oral antidiabetics].
Deckert T
Ugeskr Laeger; 1975 Jun; 137(24):1344-5. PubMed ID: 1145836
[No Abstract] [Full Text] [Related]
17. [Oral antidiabetics].
Mehnert H
Dtsch Med Wochenschr; 1977 Apr; 102(15):589. PubMed ID: 849718
[No Abstract] [Full Text] [Related]
18. [Who needs oral antidiabetics?].
Danielson M; Isaksson H
Lakartidningen; 1979 Oct; 76(40):3377-9. PubMed ID: 502673
[No Abstract] [Full Text] [Related]
19. Management of type 2 diabetes: oral agents, insulin, and injectables.
Fonseca VA; Kulkarni KD
J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
[TBL] [Abstract][Full Text] [Related]
20. Evolution and present status of oral antidiabetics in the management of diabetes mellitus.
Chhetri MK; Neelakantan C
J Indian Med Assoc; 1973 Jul; 61(1):54-9. PubMed ID: 4759072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
